Skip Ribbon Commands
Skip to main content
SharePoint
Manage PermissionsManage Permissions

Title

FDA Approves Emflaza (deflazacort) to treat Duchenne Muscular Dystrophy in February 9, 2017

Body

Expires

NewsImage

Created at 2/12/2017 14:03 by Drug Information Center
Last modified at 2/12/2017 14:04 by Drug Information Center